143 related articles for article (PubMed ID: 38379985)
1. Integrating single-cell and bulk expression data to identify and analyze cancer prognosis-related genes.
Bao S; Fan Y; Mei Y; Gao J
Heliyon; 2024 Feb; 10(4):e25640. PubMed ID: 38379985
[TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of a Malignant Cell Subset Marker-Based Polygenic Risk Score in Stomach Adenocarcinoma Through Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data.
Zou Q; Lv Y; Gan Z; Liao S; Liang Z
Front Cell Dev Biol; 2021; 9():720649. PubMed ID: 34733840
[No Abstract] [Full Text] [Related]
3. Integrating single-cell RNA-seq and bulk RNA-seq to construct prognostic signatures to explore the role of glutamine metabolism in breast cancer.
Pei S; Zhang P; Chen H; Zhao S; Dai Y; Yang L; Kang Y; Zheng M; Xia Y; Xie H
Front Endocrinol (Lausanne); 2023; 14():1135297. PubMed ID: 36843602
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models.
Li L; Liu ZP
J Transl Med; 2021 Dec; 19(1):514. PubMed ID: 34930307
[TBL] [Abstract][Full Text] [Related]
6. Analysis of expression differences of immune genes in non-small cell lung cancer based on TCGA and ImmPort data sets and the application of a prognostic model.
Sun L; Zhang Z; Yao Y; Li WY; Gu J
Ann Transl Med; 2020 Apr; 8(8):550. PubMed ID: 32411773
[TBL] [Abstract][Full Text] [Related]
7. Construction and evaluation of a nomogram for predicting survival in patients with lung cancer.
Ouyang J; Hu Z; Tong J; Yang Y; Wang J; Chen X; Luo T; Yu S; Wang X; Huang S
Aging (Albany NY); 2022 Mar; 14(6):2775-2792. PubMed ID: 35321944
[TBL] [Abstract][Full Text] [Related]
8. Construction of a fatty acid metabolism-related gene signature for predicting prognosis and immune response in breast cancer.
Qian L; Liu YF; Lu SM; Yang JJ; Miao HJ; He X; Huang H; Zhang JG
Front Genet; 2023; 14():1002157. PubMed ID: 36936412
[No Abstract] [Full Text] [Related]
9. A prognostic model of non small cell lung cancer based on TCGA and ImmPort databases.
Yang D; Ma X; Song P
Sci Rep; 2022 Jan; 12(1):437. PubMed ID: 35013450
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of single-cell and bulk RNA-seq establishes a novel signature for prediction in gastric cancer.
Wen F; Guan X; Qu HX; Jiang XJ
World J Gastrointest Oncol; 2023 Jul; 15(7):1215-1226. PubMed ID: 37546563
[TBL] [Abstract][Full Text] [Related]
11. Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma.
Zhang Z; Lin E; Zhuang H; Xie L; Feng X; Liu J; Yu Y
Cancer Cell Int; 2020; 20():27. PubMed ID: 32002016
[TBL] [Abstract][Full Text] [Related]
12. Identification of Six Novel Prognostic Gene Signatures as Potential Biomarkers in Small Cell Lung Cancer.
Feng S; Zhang X; Gu X; Zhou M; Chen Y; Wang C
Comb Chem High Throughput Screen; 2023; 26(5):938-949. PubMed ID: 35490316
[TBL] [Abstract][Full Text] [Related]
13. The combination therapy of isomucronulatol 7-O-beta-glucoside (IMG) and CEP-9722 targeting ferroptosis-related biomarkers in non-small cell lung cancer (NSCLC).
Cui X; Liu C; Dong P; Liu C; Bai Y
BMC Pulm Med; 2023 May; 23(1):162. PubMed ID: 37165402
[TBL] [Abstract][Full Text] [Related]
14. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
15. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
16. Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma.
Mi K; Zeng L; Chen Y; Yang S
Int J Gen Med; 2023; 16():5031-5050. PubMed ID: 37942473
[TBL] [Abstract][Full Text] [Related]
17. [Construction of Lung Adenocarcinoma Prognosis Model and Drug Sensitivity Analysis Based on Cuproptosis Related Genes].
Sun J; Zhang H; Liu H; Dong Y; Wang P
Zhongguo Fei Ai Za Zhi; 2023 Aug; 26(8):591-604. PubMed ID: 37752539
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
[TBL] [Abstract][Full Text] [Related]
20. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
